Philip has more than 20 years' experience writing about companies, general finance and investing matters for a variety of publications. His career has involved spells at the Investors Chronicle, where he was small companies and companies editor, Investors Week and most recently as editor of online financial news wire Sharecast. He has also contributed to a wide range of financial-focused publications on a freelance basis.
Gin market has become extremely competitive with a wave of new micro entrants
The challenge trial charts the entire disease life cycle from healthy to sick and back to health.
Aegerion is a subsidiary of Nasdaq-listed Novelion Therapeutics and the way the deal has been structured values Amryt at US$120mln
One European and one US group have the signed letters of intent for funding
Benchmark will use investment to build its presence independently in Chile
Lung cancer kills more people in Israel than any other form of the disease, said the company.
Plenity has been cleared for the BMI 25-40 kg/M2 category, the widest category of adults suffering from obesity
Placed at 76p, the shares were trading at 87.5p in first dealings
Redx said today it has £13.6mln in the bank, which should last it into early 2019
In a £1bn deal, won against five other tenders, Morrison's will supply Safeway products and other national brands to 1,300 McColl's stores and 350 newsagents
British Telecom is developing a habit for unpleasant surprises